Establishing a registry and prognostic index for mycosis fungoides, the most common type of cutaneous T-cell lymphoma (CTCL), and Sézary syndrome, a rare type of CTCL, is important to improve the management of these conditions. In this interview, Julia Scarisbrick, MBChB, FRCP, MD, of the University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, discusses the Prospective Cutaneous Lymphoma International Prognostic Indices (PROCLIPI), which is transforming this very area, and shares some of the results found. This video was recorded at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland.
PROCLIPI: registry & establishment of a prognostic index for MF and SS
